Skip to main content
. Author manuscript; available in PMC: 2006 Jun 30.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1696–1702. doi: 10.1167/iovs.05-1258

Figure 4. Overexpression of MMP-14 and TIMP-2.

Figure 4

Activity of MMP-14 (A) as measured with the Biotrak activity kit and TIMP-2 (B) as measured by reverse zymography is not significantly decreased after overexpression and injury. (I=injury) Data represents two individual experiments performed in duplicate. Data are graphed as % activity of non-injured cells.